Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Sklenar

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Experimental Hematology|November 1, 1993
Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factorsS Siena, M Bregni, L Bonsi, et al.
Bone Marrow Transplantation|February 18, 1998
Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patientsK Kolbe, C Peschel, B Rupilius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapyA M Gianni, S Siena, M Bregni, et al.
Oncology|November 1, 1993
Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myelomaI Sklenar, G Schiffman, V Jønsson, et al.
Vox Sanguinis|January 25, 2003
Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficienciesH H Wolf, S V Davies, M Borte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinomaL S Hofstra, G B Kristensen, P H Willemse, et al.
British Journal of Haematology|September 1, 1999
Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphomaR E Brouwer, E Vellenga, K H Zwinderman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Experimental Hematology|November 1, 1993
Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factorsS Siena, M Bregni, L Bonsi, et al.
Bone Marrow Transplantation|February 18, 1998
Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patientsK Kolbe, C Peschel, B Rupilius, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapyA M Gianni, S Siena, M Bregni, et al.
Oncology|November 1, 1993
Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myelomaI Sklenar, G Schiffman, V Jønsson, et al.
Vox Sanguinis|January 25, 2003
Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficienciesH H Wolf, S V Davies, M Borte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinomaL S Hofstra, G B Kristensen, P H Willemse, et al.
British Journal of Haematology|September 1, 1999
Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphomaR E Brouwer, E Vellenga, K H Zwinderman, et al.
Pageof 2